Vivorte Trabexus EB
by Vivorte, Inc
510(k) K143547
Vivorte Trabexus EB is a medical device (FDA Class II; FDA product code MBP, Filler, Bone Void, Osteoinduction (W/O Human Growth Factor)) made by Vivorte, Inc, cleared under FDA 510(k) K143547 on 14 Jan 2015, active as of 22 Oct 2026. One FDA recall is linked to it.
Active
510(k)
Valid until
No expiry
FDA recalls
None ongoingDocuments
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK143547 | Date14 Jan 2015 | StatusActive |
Official records
- FDA 510(k) database K143547
From the FDA record
- Received by the FDA
- 15 Dec 2014
- FDA decision
- 14 Jan 2015 (Substantially Equivalent)
- FDA review time
- 30 days from receipt to decision
- Public document
- 510(k) summary on file with the FDA
Recalls
-
- Terminated Z-2024-2021
incorrect expiration date- product is listed with 02-15-2019 the correct kit expiration date is 12-18-2018
Timeline
- Cleared FDA 510(k) K143547
- Recall initiated FDA recalls Z-2024-2021
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA product code
- MBP
- FDA applicant
- Vivorte, Inc.
- Device class
- Class II
- Regulation
- 21 CFR Part 888.3045
- Advisory committee
- Orthopedic
- FDA decision
- SESE Substantially Equivalent
Similar devices
Other devices filed under FDA product code MBP (Filler, Bone Void, Osteoinduction (W/O Human Growth Factor)).
- PLEXUR P by Osteotech, Inc.
- SYGNAL DBM by Musculoskeletal Transplant Foundation
- BIOSET XC by Regeneration Technologies, Inc.
- PROGENIX DBM PUTTY AND PASTE by MEDTRONIC SOFAMOR DANEK, INC.
- DBX DEMINERALIZED BONE MATRIX PUTTY, DBX DEMINERALIZED BONE MATRIX PASTE by Musculoskeletal Transplant Foundation
- OPTECURE; OPTECURE + CCC by Exactech, Inc.
- ACCELL TBM-R by ISOTIS ORTHOBIOLOGICS, INC
- OPTECURE by Exactech, Inc.
- DBX-H HEMOSTATIC DEMINERALIZED BONE MATRIX PUTTY by Orthocon, Inc.
- ACCELL EVO3 (FORMERLY ACCELL A2I) by Integra Lifesciences Corp.